Well-known inhalation industry insider joins the senior team.
22 September 2025. Nottingham, UK: Copley Scientific, the world’s leading supplier and manufacturer of inhaled product testing equipment, is pleased to announce that Paul Martin has joined the company as Head of Business Development. A seasoned business development professional, Paul has been working with respiratory products for more than a decade and is already a familiar face to many in the inhalation community. He strengthens a team committed to delivering exceptional pharmaceutical testing equipment, for inhaled products and other product forms, to customers across the globe.
“I’m delighted to welcome Paul to the Copley team,” said Jamie Clayton, CEO. “We already know him well from his time at Intertek Melbourn and we’re confident he’s a great fit. We look forward to working with Paul and I know he’s eager to develop productive relationships with our customers, many of whom will have met him already.”
Paul began his career in the respiratory product industry at GSK where he supported the launch of the Ellipta® portfolio into primary care, later moving into the contract manufacturing and testing side of the market. Business development has been a constant theme throughout his career, most recently as Associate Director of Business Development at Intertek Melbourn, a company renowned for its specialist expertise in inhaled product development.
“If you work with inhaled products then you know Copley,” said Paul. “It’s great to be joining a company that combines a strong heritage with an innovative, forward-looking approach. I’m excited to begin supporting customers with solutions that truly make a difference.”
Paul’s appointment underlines Copley’s commitment to supporting an unrivalled inhaled product testing portfolio with relevant, highly specialised expertise. The result is best-in-class solutions that efficiently solve the real-world challenges faced by those developing and manufacturing orally inhaled and nasal drug products (OINDPs).
Customers attending the MVIC Symposium in Lund, 8-9 October, will have the opportunity to meet Paul in person and explore how Copley’s comprehensive OINDP testing portfolio can support their end-to-end development, QC, and regulatory needs.
Jamie Clayton, Chief Executive Officer (left), welcomes Paul Martin (right) as Head of Business Development to Copley Scientific.
About Copley Scientific
Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaled product testing equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing.
Copley’s pharmaceutical product range includes testing equipment for all types of orally inhaled and nasal drug products – metered-dose inhalers, dry powder inhalers, nebulisers and nasal products – with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals.
Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley works in partnership with specialist distributors, extending localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com
